Klinische Studien und ihre Ergebnisse Erste klinische Studien konzentrieren sich auf das Potenzial von BPC-157 zur Heilung von Verletzungen und zur Verbesserung der Geweberegeneration
Understanding exactly what GLP-1 medications do to these systems explains why eating changes so dramatically, why certain side effects occur, and why specific nutritional strategies work while others fail
Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors
It is important to mention that this growth is not uniform but rather disproportionately driven by innovative peptide therapeutics, which demand higher margins and benefit from stronger intellectual property protection
Retatrutide is an investigational pharmaceutical agent currently under clinical development and does not hold a marketing authorisation from the MHRA or the European Medicines Agency (EMA)
[4] Ahmann AJ, Capehorn M, Charpentier G, Dotta F, Henkel E, Lingvay I, Holst AG, Annett MP, Aroda VR